Trends in the Use of Oral Anticoagulants and Associated Expenditures Among Medicaid Programs-Reference-Cited by-同舟云学术

Trends in the Use of Oral Anticoagulants and Associated Expenditures Among Medicaid Programs

Published:2021-11 Issue:1 Volume:1 Page:
ISSN:2694-5746
Container-title:Stroke: Vascular and Interventional Neurology
language:en
Short-container-title:SVIN

Author:

Kim Youngran¹,Khose Swapnil¹,Zhang Guo‐Qiang¹,Krause Trudy Millard²,McCullough Louise D.¹,Vahidy Farhaan S.³,Sheth Sunil A.¹^ORCID

Affiliation:

1. Department of Neurology, McGovern Medical School The University of Texas Health Science Center at Houston Houston TX

2. Division of Management, Policy and Community Health, School of Public Health The University of Texas Health Science Center at Houston Houston TX

3. Center for Outcomes Research and Houston Methodist Neurological Institute Houston Methodist Houston TX

Publisher

Ovid Technologies (Wolters Kluwer Health)

Link

https://www.ahajournals.org/doi/pdf/10.1161/SVIN.121.000146

Reference5 articles.

1. Use of direct oral anticoagulants among patients with limited income and resources;Ting C;J Am Coll Cardiol,2019

2. Contemporary trends in oral anticoagulant prescription in atrial fibrillation patients at low to moderate risk of stroke after guideline‐recommended change in use of the CHADS2 to the CHA2DS2‐VASc score for thromboembolic risk assessment;Katz DF;Circ Cardiovasc Qual Outcomes,2017

3. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

4. Medicare part D prescribing for direct oral anticoagulants in the United States: Cost, use and the “rubber effect”

5. Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population